X
X
X
We have sent you an email to . Please click on the link in the email to confirm your emailID.
Loading ! Please wait...
Buzzing now
http://rediff.ly/oi8xg
Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms... Read more »»
http://rediff.ly/oi8xg
Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.
#REDIFFNEWS
#Lupin
http://rediff.ly/oh9dp
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from... Read more »»
http://rediff.ly/oh9dp
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.
#REDIFFNEWS
#Zydus_Cadila
http://rediff.ly/ogst4
An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the... Read more »»
http://rediff.ly/ogst4
An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.
#REDIFFNEWS
#Subject_Expert_Committee_of_the_Central_Drugs_Standard_Control_Organisation
http://rediff.ly/o5smh
Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for... Read more »»
http://rediff.ly/o5smh
Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.
#REDIFFNEWS
#Pfizer
http://rediff.ly/o563p
'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
......... Read more »»
http://rediff.ly/o563p
'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
#REDIFFNEWS
#Dr_V_G_Somani
http://rediff.ly/o408u
Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with... Read more »»
http://rediff.ly/o408u
Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.
#REDIFFNEWS
http://rediff.ly/o1eys
'We are hoping by March, the government allows us to export and give it to the private market.'
#REDIFFNEWS
......... Read more »»
http://rediff.ly/o1eys
'We are hoping by March, the government allows us to export and give it to the private market.'
#REDIFFNEWS
#Serum_Institute_of_India
http://rediff.ly/nyywj
'Ideally, the efficacy data of all the trials should be there in the public domain, and as soon as possible.' 'It is... Read more »»
http://rediff.ly/nyywj
'Ideally, the efficacy data of all the trials should be there in the public domain, and as soon as possible.' 'It is difficult to understand the reason behind the authorisation.'
#REDIFFNEWS
#ANI_Photo
http://rediff.ly/nxzli
Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already... Read more »»
http://rediff.ly/nxzli
Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.
#REDIFFNEWS
#Adar_Poonawalla
http://rediff.ly/nxdfx
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical... Read more »»
http://rediff.ly/nxdfx
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.
#REDIFFNEWS
#Covaxin
© 2021 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Careers - Feedback - Sitemap | Terms of use